This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. Circassia Inc. was awarded the IDV with a potential value of $30.4 million and a period of performance through March 2025. The IDV facilitates the acquisition of drugs, pharmaceuticals, and hematology-related products through task orders or delivery orders issued...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. West Therapeutic Development, LLC was awarded the IDV as the prime contractor. The IDV aims to procure a range of drugs, pharmaceuticals, and hematology-related products over a four year period ending in January 2024, with a potential value of $225,000. No set-asides were...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The prime contractor is Q Biomed Inc. With a potential value of $225,000 and a period of performance through February 2026, the contract aims to deliver 65 I B drugs, pharmaceuticals, and hematology-related products to VA medical treatment facilities in the region. The...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a for-profit manufacturer of pharmaceutical and healthcare products. The contract, valued at $32,885,990.00, is for the provision of pharmaceuticals, drugs, and hematology-related products (FSS-61-IB) to the VA and other federal agencies. The contract has an ultimate completion date of September 1, 2025 and was originally awarded on April 15, 2017. It is...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 12. The prime contractor is Alpha Cognition USA, Inc., a for-profit manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance through September 30, 2025. It is a multiple award IDV, meaning...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. Hill Dermaceuticals Inc. was awarded the IDV with a potential value of $225,000. No set-aside was used. Products and services must be delivered by January 14, 2023. The IDV aims to procure drugs, pharmaceuticals, and hematology-related products listed in GSA Schedule 65...
The federal contract indefinite delivery vehicle (IDV) award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The prime contractor, Gold Coast Medical Supply LP, has been awarded this multiple-award contract by the Veterans Integrated Service Network 12 (VISN 12), which is a part of the Department of Veterans Affairs (VA) - Veterans Health Administration (VHA). The contract, valued at a ceiling of $7,400,000.00, is for the procurement of...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therapeuticsmd, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award contract has a potential value of $250,000.00 and a period of performance from May 15, 2020 to May 15, 2024. Therapeuticsmd, Inc.,...
The federal contract IDV award is for pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The multiple award IDV was granted by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Rockwell Medical, Inc. on March 1, 2021, with a potential value of $250,000 and period of performance through December 15, 2022. The IDV facilitates delivery of drugs, pharmaceuticals, and hematology-related products to...